Patent details

Basic Information

Publication number:

EP2175859

PCT Application Number:

PCT/US/2008/069813

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087817094

PCT Publication Number:

WO/2009/009740

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREAMENT OF INFLAMMATION

French Title of Invention:

HÉTÉROARYL-PYRIDYL- ET PHÉNYL-BENZÈNESULFONAMIDES CONDENSÉS EN TANT QUE MODULATEURS DU CCR2 POUR LE TRAITEMENT DE L'INFLAMMATION

German Title of Invention:

KONDENSIERTE HETEROARYLPYRIDYL- UND PHENYLBENZENSULFONAMIDE ALS CCR2-MODULATOREN ZUR BEHANDLUNG VON ENTZÜNDUNGEN

SPC Number:

Dates

Filing date:

11/07/2008

Grant date:

07/03/2012

EP Publication Date:

07/03/2012

PCT Publication Date:

15/01/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/04/2010

EP B1 Publication Date:

07/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/07/2012

Expiration date:

11/07/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/07/2008

 

 

Name:

ChemoCentryx Inc.

Address:

850 Maude Avenue, Mountain View California 94043, United States (US)

Inventor

1

Name:

ZENG Yibin

Address:

United States (US)

2

Name:

WANG Qiang

Address:

United States (US)

3

Name:

UNGASHE Solomon

Address:

United States (US)

4

Name:

PUNNA Sreenivas

Address:

United States (US)

5

Name:

KRASINSKI Antoni

Address:

United States (US)

Priority

Priority Number:

949328 P

Priority Date:

12/07/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/519;

Filing date	Document type	Number of pages